Comment from the Editor to the Special Issue: “Big Data and Precision Medicine Series I: Lung Cancer Early Diagnosis”
Abstract
:Acknowledgments
Conflicts of Interest
References
- Gasparri, R.; Romano, R.; Sedda, G.; Borri, A.; Petrella, F.; Galetta, D.; Casiraghi, M.; Spaggiari, L. Diagnostic biomarkers for lung cancer prevention. J. Breath Res. 2018, 12, 027111. [Google Scholar] [CrossRef] [PubMed]
- Mayer-Schönberger, V.; Ingelsson, E. Big Data and medicine: A big deal? J. Intern. Med. 2017. [Google Scholar] [CrossRef] [PubMed]
- Williams, A.M.; Liu, Y.; Regner, K.R.; Jotterand, F.; Liu, P.; Liang, M. Artificial intelligence, physiological genomics, and precision medicine. Physiol. Genom. 2018. [Google Scholar] [CrossRef] [PubMed]
- Rivers, R.C.; Kinsinger, C.; Boja, E.S.; Hiltke, T.; Mesri, M.; Rodriguez, H. Linking cancer genome to proteome: NCI’s investment into proteogenomics. Proteomics 2014, 14, 2633–2636. [Google Scholar] [CrossRef] [PubMed]
© 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Gasparri, R.; Sedda, G.; Spaggiari, L. Comment from the Editor to the Special Issue: “Big Data and Precision Medicine Series I: Lung Cancer Early Diagnosis”. J. Clin. Med. 2018, 7, 28. https://doi.org/10.3390/jcm7020028
Gasparri R, Sedda G, Spaggiari L. Comment from the Editor to the Special Issue: “Big Data and Precision Medicine Series I: Lung Cancer Early Diagnosis”. Journal of Clinical Medicine. 2018; 7(2):28. https://doi.org/10.3390/jcm7020028
Chicago/Turabian StyleGasparri, Roberto, Giulia Sedda, and Lorenzo Spaggiari. 2018. "Comment from the Editor to the Special Issue: “Big Data and Precision Medicine Series I: Lung Cancer Early Diagnosis”" Journal of Clinical Medicine 7, no. 2: 28. https://doi.org/10.3390/jcm7020028